Mats Wahlstrom - Feb 1, 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Mats Wahlstrom
Stock symbol
CHRS
Transactions as of
Feb 1, 2024
Transactions value $
$100,000
Form type
4
Date filed
2/5/2024, 07:03 PM
Previous filing
Aug 14, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Options Exercise $25K +15K +37.49% $1.67 55K Feb 1, 2024 Direct F1
transaction CHRS Common Stock Options Exercise $75K +45K +81.81% $1.67 100K Feb 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Options Exercise $0 -15K -100% $0.00* 0 Feb 1, 2024 Common Stock 15K $1.67 Direct F2
transaction CHRS Stock Option (Right to Buy) Options Exercise $0 -45K -100% $0.00* 0 Feb 1, 2024 Common Stock 45K $1.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price.
F2 The option is fully vested and exercisable.